M2 Worldwide

M2 Worldwide (M2W) was a premier global agency specializing in patient recruitment and retention for clinical trials within the life sciences sector. The company provided end-to-end services designed to accelerate the drug development process by identifying, enrolling, and retaining qualified participants for complex clinical studies. M2 Worldwide utilized a combination of data analytics, site-specific support, and patient-centric communication strategies to meet enrollment targets across various therapeutic areas. In 2014, the firm was acquired by Publicis Health and was later integrated into Langland to form a comprehensive clinical trial experience offering. This integration combined M2W's recruitment expertise with Langland's creative and strategic capabilities to serve global pharmaceutical clients.